Physician profile
Bryan K Cho
NPI 1891811600
$245.00
in general payments reported to CMS, 2019-2025
9 companies · $87.01 in 2025
The $87.01 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.89 · 2021: $12.49 · 2024: $133 · 2025: $87.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $51.90 | 2024 | Opzelura |
| Genzyme Corporation | $41.28 | 2025 | |
| Lilly USA, LLC | $33.34 | 2024 | Taltz, Ebglyss |
| Abbvie INC. | $26.70 | 2025 | |
| Galderma Laboratories, L.P. | $25.29 | 2024 | |
| Arcutis Biotherapeutics, INC. | $22.08 | 2024 | Zoryve |
| Almirall LLC | $19.03 | 2025 | Klisyri |
| Sun Pharmaceutical Industries INC. | $12.89 | 2020 | |
| Allergan, INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.